{"id":"JGAD000288","research":"hum0014","url":"https://humandbs.dbcls.jp/dataset/JGAD000288","datePublished":"2020-09-28","dateModified":"2020-09-28","values":[{"key":"access-criteria","label":{"ja":"アクセス制限","en":"Access criteria"},"type":"vocabulary","terms":[{"code":"controlled-access-type-1","label":{"ja":"制限公開（Type I）","en":"Controlled-access (Type I)"}}]},{"key":"type-of-data","label":{"ja":"データの種類","en":"Type of data"},"type":"text","text":{"ja":"遺伝性前立腺がん7,636症例と対照者12,366名の遺伝性前立腺がん原因8遺伝子翻訳領域のTarget Capture Sequencingデータ","en":"target sequencing of 8 hereditary prostate cancer genes in 7,636 prostate cancer patients and 12,366 controls"}}],"experiments":[{"label":{"ja":"Targeted DNA sequencing","en":"Targeted DNA sequencing"},"values":[{"key":"materials-and-participants","label":{"ja":"材料と対象者","en":"Materials and participants"},"type":"text","text":{"ja":"遺伝性前立腺がん（ICD10：C61）：7,636症例\n対照者：12,366名","en":"7,636 prostate cancer patients (ICD10: C61) and 12,366 controls"}},{"key":"disease","label":{"ja":"疾患","en":"Disease"},"type":"disease","diseases":[{"terms":[{"code":"C61","label":{"ja":"前立腺の悪性新生物＜腫瘍＞","en":"Malignant neoplasm of prostate"}}],"name":{"ja":"遺伝性前立腺がん","en":"prostate cancer patients"}}]},{"key":"health-status","label":{"ja":"健康状態","en":"Health status"},"type":"vocabulary","terms":[{"code":"mixed","label":{"ja":"混在","en":"Mixed"}}]},{"key":"subject-count","label":{"ja":"対象者数","en":"Subject count"},"type":"number","numbers":[{"value":20002,"unit":null,"high":null}]},{"key":"subject-count-type","label":{"ja":"対象者数の数え方","en":"Counted as"},"type":"vocabulary","terms":[{"code":"individual","label":{"ja":"人数","en":"Individual"}}]},{"key":"sample-description","label":{"ja":"試料説明","en":"Sample description"},"type":"text","text":{"ja":"末梢血から抽出したgDNA","en":"DNA extracted from peripheral blood cells"}},{"key":"tissue","label":{"ja":"組織","en":"Tissue"},"type":"vocabulary","terms":[{"code":"peripheral-blood","label":{"ja":"末梢血","en":"Peripheral blood"}}]},{"key":"is-tumor","label":{"ja":"腫瘍 / 非腫瘍","en":"Tumor / normal"},"type":"vocabulary","terms":[{"code":"normal","label":{"ja":"非腫瘍","en":"Normal"}}]},{"key":"sample-provider","label":{"ja":"試料の入手元","en":"Sample provider"},"type":"text","text":{"ja":null,"en":null}},{"key":"experimental-method","label":{"ja":"実験方法","en":"Experimental method"},"type":"vocabulary","terms":[{"code":"targeted-dna-sequencing","label":{"en":"Targeted DNA sequencing"}}]},{"key":"targets","label":{"ja":"測定対象","en":"Target"},"type":"text","text":{"ja":"遺伝性前立腺がんの原因8遺伝子（ATM, BRCA1, BRCA2, BRIP1, CHEK2, HOXB13, NBN, PALB2）の翻訳領域","en":"8 hereditary prostate cancer genes (ATM, BRCA1, BRCA2, BRIP1, CHEK2, HOXB13, NBN, PALB2)"}},{"key":"reagents","label":{"ja":"試薬キット","en":"Reagent kit"},"type":"vocabulary","terms":[{"code":"2x-platinum-multiplex-pcr-master-mix","label":{"en":"2X Platinum Multiplex PCR Master Mix"}},{"code":"kapa-hifi-dna-polymerase","label":{"en":"KAPA HiFi DNA Polymerase"}}]},{"key":"fragmentation","label":{"ja":"断片化","en":"Fragmentation"},"type":"text","text":{"ja":null,"en":null}},{"key":"platform","label":{"ja":"プラットフォーム","en":"Platform"},"type":"vocabulary","terms":[{"code":"illumina-hiseq-2500","label":{"en":"Illumina HiSeq 2500"}}]},{"key":"read-type","label":{"ja":"リードタイプ","en":"Read type"},"type":"vocabulary","terms":[{"code":"paired-end","label":{"ja":"ペアエンド","en":"Paired-end"}}]},{"key":"read-length","label":{"ja":"リード長","en":"Read length"},"type":"number","numbers":[{"value":150,"unit":"bp","high":null}]},{"key":"policies","label":{"ja":"利用ポリシー","en":"Data use policy"},"type":"vocabulary","terms":[{"code":"nbdc-data-sharing-policy-jgap000001","label":{"ja":"NBDC データ共有ポリシー (JGAP000001)","en":"NBDC data sharing policy (JGAP000001)"}}]}]}],"dataVolume":2355422776096,"fileFormats":[{"code":"fastq","label":{"en":"FASTQ"}}]}